German Health Insurance Reform: Higher Co-payments Proposed

by Priyanka Patel

Germany’s healthcare system is facing a critical financial crossroads, with a looming deficit that has prompted the federal government to propose a sweeping overhaul of how statutory health insurance is funded, and managed. Health Minister Nina Warken (CDU) has unveiled a reform package designed to stave off a massive financial collapse, signaling that the era of low-cost, comprehensive coverage without contribution may be shifting.

The urgency of the situation is underscored by a report from an expert commission, which estimated a potential funding gap of 15 billion euros for the coming year. To address this, Warken intends to rapidly implement approximately three-quarters of the 66 recommendations put forward by the commission in late March. The goal is to stabilize the system and preserve insurance contributions “nearly” constant, though this stability comes at a cost to patients, providers, and the pharmaceutical industry.

The proposed changes represent a fundamental shift in the social contract of German healthcare, moving more of the financial burden onto the individual. While the government frames these as necessary measures to prevent a much larger spike in monthly premiums for employees and employers, critics argue the plan merely shifts costs rather than solving the systemic inefficiency.

Bundesgesundheitsministerin Warken (CDU) spricht während einer Pressekonferenz zu den geplanten Reformmaßnahmen für die gesetzliche Krankenkasse.

Bundesgesundheitsministerin Warken hat Maßnahmen zur Entlastung der gesetzlichen Krankenkassen vorgestellt. Unter anderem sollen die Zuzahlungen für Medikamente angehoben werden.

14.04.2026 | 1:42 min


Direct Impacts on Patients and Families

For the average insured citizen, the most immediate change will be felt at the pharmacy counter. The current co-payment for prescription medications, which ranges from 5 to 10 euros, is slated to increase to a range of 7.50 to 15 euros. This move is part of a broader strategy to reduce the financial pressure on statutory health insurance funds by increasing the “out-of-pocket” share for patients.

Beyond medication, the government plans to tighten the scope of what the insurance will cover. Costs for homeopathic treatments and asymptomatic skin cancer screenings—previously available every two years—would no longer be reimbursed by the state. These cuts target services that the government deems less critical or evidence-based in the context of a financial emergency.

Perhaps the most contentious change involves the “family insurance” model. Currently, many spouses and family members can be insured without paying separate contributions. Warken proposes a “modification” of this system starting in 2028. While children, parents of young children (under seven), parents of children with disabilities, caring relatives, and retirees will remain covered for free, other previously free-of-charge spouses would be required to pay a contribution of 3.5 percent.

A Broad-Spectrum Reduction Strategy

The reform does not only target patients; it seeks efficiencies across the entire medical infrastructure. The government is looking to trim the administrative overhead of the insurance funds themselves, with plans to halve advertising expenditures and cap the compensation for executives within the funds and the Associations of Statutory Health Insurance Physicians (Kassenärztliche Vereinigungen).

Medical practitioners and clinics are also facing tighter constraints. In clinics, a clause allowing for higher remuneration increases will be removed, and the government intends to mandate a second medical opinion before certain high-cost procedures are performed. For private practices, payments for specific services—such as open consultation hours or the initial upload of patient data into electronic health records—will be stripped from budgets that previously existed outside general honorarium caps.

The pharmaceutical industry is expected to face stricter pricing rules and a shift toward more aggressive discount contracts to lower the cost of drug procurement. Apothecaries will witness an increase in certain discounts, though the government has promised a corresponding increase in fixed honorariums to balance the impact.

Summary of Proposed Financial Changes (Selected)
Stakeholder Proposed Change Timeline/Amount
Patients Medication Co-payments Increase to €7.50 – €15
Spouses Family Insurance Contribution 3.5% (Starting 2028)
Insurance Funds Advertising Budget Reduced by 50%
Industry Drug Pricing New “Sparregeln” (Savings Rules)

Political Friction and Unresolved Disputes

The plan has already drawn sharp criticism from social advocacy groups. Joachim Rock, Managing Director of the Paritätischer Gesamtverband, characterized the measures as “cost shifts” rather than genuine savings. According to Rock, the government is essentially “relieving itself at the expense of the contributors,” arguing that the changes to family insurance will hit low-income households particularly hard.

Political Friction and Unresolved Disputes

several high-profile “battleground” issues have been omitted from the current draft. A proposed “sugar tax” on sweetened beverages and the introduction of a “Karenztag”—a policy where employees would not receive sick pay for the first day of illness—remain unresolved. Minister Warken stated that these issues fall under the jurisdiction of other ministries, effectively distancing her office from the political fallout of those specific decisions.

One of the most significant points of contention is the funding for the healthcare of Bürgergeld (citizen’s benefit) recipients. An expert commission suggested that the cost, estimated at 12 billion euros for 2027, should be covered by tax revenue rather than insurance funds. However, Finance Minister Lars Klingbeil (SPD) has so far rejected this proposal. Warken admitted that while arguments have been exchanged, no solution has been reached between the two ministries.

ZDF-Hauptstadtkorrespondentin Britta Spiekermann

Für eine Umsetzung der Gesundheitsreformen brauche es viel Abstimmung in der Koalition, sagt ZDF-Hauptstadtkorrespondentin Spiekermann.

30.03.2026 | 5:53 min


The Path Forward

The government is moving quickly to avoid a financial crisis in the statutory insurance system. The draft legislation is expected to be deliberated by the Federal Cabinet within the next few weeks before being introduced to the Bundestag. The black-red coalition aims to reach a final decision before the summer break.

Whether these measures will be sufficient to close the 15-billion-euro gap without triggering a political backlash remains to be seen. For now, the focus remains on the legislative process and the potential for further concessions from the Finance Ministry regarding the funding of social welfare healthcare.

Disclaimer: This article is for informational purposes only and does not constitute legal or financial advice regarding health insurance. Please consult with a licensed insurance advisor or legal professional for specific guidance on your coverage.

The next critical checkpoint will be the Federal Cabinet meeting, where the final wording of the reform package will be approved before it moves to parliamentary debate. We will continue to track the progress of this legislation.

What do you suppose about the proposed changes to family insurance and medication co-payments? Share your thoughts in the comments or share this story with others affected by these reforms.

You may also like

Leave a Comment